Renaissance Technologies (RenTech)'s PETS Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 1.19 M shares of PetMed Express, Inc. (PETS) worth $2.7 M, representing 0.00% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 52 quarters.
Based on 13F filings since 2013, Renaissance Technologies (RenTech) has maintained a long-term strategic position in PETS, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2013, adding 276,800 shares. Largest reduction occurred in Q2 2024, reducing 318,215 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s PetMed Express (PETS) Holding Value Over Time
Track share changes against reported price movement
Quarterly PetMed Express (PETS) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -40,200 | Reduce 3.28% | 1.19 M | $2.28 |
| Q4 2025 | -42,400 | Reduce 3.34% | 1.23 M | $3.20 |
| Q3 2025 | -4,900 | Reduce 0.38% | 1.27 M | $2.51 |
| Q2 2025 | -7,300 | Reduce 0.57% | 1.27 M | $3.32 |
| Q1 2025 | +5,300 | Add 0.42% | 1.28 M | $4.19 |
| Q4 2024 | -27,400 | Reduce 2.10% | 1.28 M | $4.82 |
| Q3 2024 | +38,700 | Add 3.06% | 1.3 M | $3.68 |
| Q2 2024 | -318,215 | Reduce 20.10% | 1.26 M | $4.05 |
| Q1 2024 | +238,500 | Add 17.74% | 1.58 M | $4.79 |
| Q4 2023 | +205,900 | Add 18.09% | 1.34 M | $7.56 |
| Q3 2023 | +119,915 | Add 11.77% | 1.14 M | $10.25 |
| Q2 2023 | +50,200 | Add 5.18% | 1.02 M | $0.01 |
| Q1 2023 | +35,100 | Add 3.76% | 968,269 | $0.02 |
| Q4 2022 | -37,600 | Reduce 3.87% | 933,169 | $0.02 |
| Q3 2022 | -206,015 | Reduce 17.51% | 970,769 | $19.52 |
| Q2 2022 | +204,000 | Add 20.97% | 1.18 M | $19.90 |
| Q1 2022 | +156,300 | Add 19.14% | 972,784 | $25.80 |
| Q4 2021 | -2,685 | Reduce 0.33% | 816,484 | $25.26 |
| Q3 2021 | -53,904 | Reduce 6.17% | 819,169 | $26.87 |
| Q2 2021 | -96,900 | Reduce 9.99% | 873,073 | $31.85 |
| Q1 2021 | -288,100 | Reduce 22.90% | 969,973 | $35.18 |
| Q4 2020 | -276,596 | Reduce 18.02% | 1.26 M | $32.06 |
| Q3 2020 | -64,100 | Reduce 4.01% | 1.53 M | $31.62 |
| Q2 2020 | -15,400 | Reduce 0.95% | 1.6 M | $35.64 |
| Q1 2020 | -2,231 | Reduce 0.14% | 1.61 M | $28.78 |
| Q4 2019 | -5,800 | Reduce 0.36% | 1.62 M | $23.52 |
| Q3 2019 | -292,715 | Reduce 15.29% | 1.62 M | $18.02 |
| Q2 2019 | +259,100 | Add 15.65% | 1.91 M | $15.67 |
| Q1 2019 | -128,800 | Reduce 7.22% | 1.66 M | $22.78 |
| Q4 2018 | +36,200 | Add 2.07% | 1.78 M | $23.26 |
| Q3 2018 | +96,215 | Add 5.82% | 1.75 M | $33.01 |
| Q2 2018 | +19,200 | Add 1.18% | 1.65 M | $44.05 |
| Q1 2018 | -1,900 | Reduce 0.12% | 1.63 M | $41.75 |
| Q4 2017 | -233,715 | Reduce 12.51% | 1.63 M | $45.50 |
| Q3 2017 | +221,215 | Add 13.43% | 1.87 M | $33.15 |
| Q2 2017 | -138,915 | Reduce 7.78% | 1.65 M | $40.60 |
| Q1 2017 | +188,615 | Add 11.81% | 1.79 M | $20.14 |
| Q4 2016 | +29,785 | Add 1.90% | 1.6 M | $23.07 |
| Q3 2016 | -94,400 | Reduce 5.68% | 1.57 M | $20.28 |
| Q2 2016 | +47,815 | Add 2.96% | 1.66 M | $18.76 |
| Q1 2016 | -89,820 | Reduce 5.27% | 1.61 M | $17.91 |
| Q4 2015 | -69,295 | Reduce 3.91% | 1.7 M | $17.14 |
| Q3 2015 | +146,215 | Add 8.98% | 1.77 M | $16.10 |
| Q2 2015 | -57,632 | Reduce 3.42% | 1.63 M | $17.27 |
| Q1 2015 | +84,417 | Add 5.27% | 1.69 M | $16.52 |
| Q4 2014 | +11,400 | Add 0.72% | 1.6 M | $14.37 |
| Q3 2014 | -106,192 | Reduce 6.26% | 1.59 M | $13.60 |
| Q2 2014 | -121,801 | Reduce 6.70% | 1.7 M | $13.48 |
| Q1 2014 | -75,807 | Reduce 4.00% | 1.82 M | $13.41 |
| Q4 2013 | +262,100 | Add 16.07% | 1.89 M | $16.63 |
| Q3 2013 | +276,800 | Add 20.44% | 1.63 M | $16.28 |
| Q2 2013 | +1.35 M | Add 0.00% | 1.35 M | $12.60 |
Renaissance Technologies (RenTech)'s PetMed Express Investment FAQs
Renaissance Technologies (RenTech) first purchased PetMed Express, Inc. (PETS) in Q2 2013, acquiring 1,354,115 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held PetMed Express, Inc. (PETS) for 52 quarters since Q2 2013.
Renaissance Technologies (RenTech)'s largest addition to PetMed Express, Inc. (PETS) was in Q2 2013, adding 1,354,115 shares worth $17.06 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 1,186,369 shares of PetMed Express, Inc. (PETS), valued at approximately $2.7 M.
As of the Q1 2026 filing, PetMed Express, Inc. (PETS) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in PetMed Express, Inc. (PETS) was 1,914,915 shares, as reported at the end of Q2 2019.